Key result
Depleting neutrophils with anti-Ly6G antibodies reduced arrested neutrophils in myocardial capillaries, improving myocardial hypoxia and diastolic function in a mouse model of HFpEF.
Why the study?
Impairments in myocardial blood flow occur in HFpEF, but the underlying mechanisms and roles in pathogenesis remain poorly understood.
Does neutrophil depletion with a-Ly6G improve diastolic function and myocardial hypoxia in a mouse model of HFpEF?
Does neutrophil depletion with a-Ly6G improve diastolic function and myocardial hypoxia in a mouse model of HFpEF?
Neutrophil stalling in myocardial capillaries contributes to hypoxia and diastolic dysfunction in HFpEF, and targeted depletion of neutrophils restores perfusion and cardiac function in a preclinical mouse model.
Neutrophil-mediated capillary flow defects may drive HFpEF microvascular impairment; leaves open therapeutic targeting and human translation.
Impairments in myocardial blood flow have been recognized for decades in human patients with and animal models of heart failure with preserved ejection fraction (HFpEF), but the underlying mechanisms and roles in pathogenesis remain poorly understood. Using intravital cardiac microcopy in a ‘two-hit’ mouse model of HFpEF that combines high fat diet and inhibition of nitric oxide synthase, we identified an increase in slow or non-flowing neutrophils in capillaries compared to Control mice. In other mouse models of disease (e.g., in the brain of Alzheimer’s Disease mice), the presence of such ‘stalled’ neutrophils leads to organ-wide decreases in perfusion and oxygenation. Administration of antibodies against the neutrophil surface protein Ly6G to deplete neutrophils reduced the number of arrested neutrophils in myocardial capillaries, leading to improvements in myocardial hypoxia, diastolic function, and exercise capacity. This study identifies a previously uncharacterized cellular mechanism that explains myocardial blood flow deficits in mouse models of HFpEF, and demonstrates that improving myocardial blood flow improves cardiac function, without necessitating reversal of pathologic remodeling. Restoring myocardial perfusion by decreasing neutrophil arrest in myocardial capillaries may provide a strategy for improving heart function in HFpEF patients in the future.
No takes yet. Share an insight, caveat, or question.
Buglione et al. (2025) studied Heart failure with preserved ejection fraction (HFpEF). Anti-Ly6G antibody vs. Isotype control antibody was evaluated on Neutrophil arrest in myocardial capillaries, myocardial hypoxia, and diastolic function (E/E' ratio). Depleting neutrophils with anti-Ly6G antibodies reduced arrested neutrophils in myocardial capillaries, improving myocardial hypoxia and diastolic function in a mouse model of HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: